Characterization by Spectroscopic, Kinetic and Equilibrium Methods of the Interaction Between Recombinant Human Cystatin A (stefin A) and Cysteine Proteinases
Overview
Authors
Affiliations
The near-UV spectroscopic changes induced by the binding of recombinant human cystatin A to papain were appreciably different from those induced by cystatin C, reflecting mainly interactions involving the single tryptophan of cystatin C, Trp-106. Cystatin A bound tightly and rapidly to papain and cathepsin L, with dissociation equilibrium constants of approximately 10(-11)-10(-13) M and association rate constants of 3 x 10(6)-5 x 10(6) M-1.s-1. These affinities are at least 50-100-fold higher than previously reported values. The kinetics of binding to papain were consistent with a simple reversible bimolecular reaction mechanism, indicating that cystatin A, like chicken cystatin and cystatin C, binds to papain with no appreciable conformational adaptation of either reacting protein. Cystatin A bound more weakly to actinidin and cathepsins B, C and H, with dissociation equilibrium constants of 10(-8)-10(-9) M. The weaker binding to cathepsin B was largely due to a considerably reduced association rate constant (approximately 4 x 10(4) M-1.s-1), consistent with the 'occluding loop' of cathepsin B markedly restricting the access of cystatin A to the active site. The lower affinities for actinidin and cathepsins C and H were due partly to lower association rate constants (2 x 10(5)-6 x 10(5) M-1.s-1) but primarily to higher dissociation rate constants. The mode of binding of cystatin A to inactivated papains indicated that there is appreciably less space around the active-site cysteine of papain in the complex with cystatin A than in the complexes with chicken cystatin and cystatin C. An N-terminally truncated form of cystatin A, lacking the first six residues, had considerably lower affinity for papain than the full-length inhibitor, consistent with an intact N-terminal region being of importance for proteinase binding.
Hoffmann T, Stadler L, Busby M, Song Q, Buxton A, Wagner S Protein Eng Des Sel. 2010; 23(5):403-13.
PMID: 20179045 PMC: 2851446. DOI: 10.1093/protein/gzq012.
Inhibition of mammalian cathepsins by Plesiomonas shigelloides.
Pavlova A, Krovacek K, Ciznar I, Gonzalez-Rey C Folia Microbiol (Praha). 2006; 51(5):393-400.
PMID: 17176758 DOI: 10.1007/BF02931582.
Purification and characterization of kininogens from sheep plasma.
Baba S, Zehra S, Bano B Protein J. 2005; 24(2):95-102.
PMID: 16003951 DOI: 10.1007/s10930-004-1516-6.
Proteolysis and antigen presentation by MHC class II molecules.
Bryant P, Lennon-Dumenil A, Fiebiger E, Lagaudriere-Gesbert C, Ploegh H Adv Immunol. 2002; 80:71-114.
PMID: 12078484 PMC: 7130937. DOI: 10.1016/s0065-2776(02)80013-x.
Pol E, BJORK I Protein Sci. 2001; 10(9):1729-38.
PMID: 11514663 PMC: 2253190. DOI: 10.1110/ps.11901.